STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
加入 July 2015
4.7K 正在關注 165.1K 粉絲
At the European Society of Cardiology Congress this weekend:
• Novartis drug successfully lowered signs of inflammation in mid-stage study
• AstraZeneca shared details on the surprise failure of its “silencer” drug
Read more takeaways here:
顯示更多
